These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31981839)

  • 1. Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders.
    Hentzen C; Turmel N; Chesnel C; Charlanes A; Le Breton F; Sheikh Ismaël S; Amarenco G
    Ann Phys Rehabil Med; 2020 Mar; 63(2):106-110. PubMed ID: 31981839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of need to void on Parkinsonian gait.
    Savard E; Chesnel C; Declemy A; Hentzen C; Charlanes A; Le Breton F; Amarenco G
    Prog Urol; 2020 Jun; 30(7):390-395. PubMed ID: 32156452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between desire to void and bladder capacity and rectal sensory function in patients with multiple sclerosis and anorectal disorders.
    Pouyau C; Grasland M; Leroux C; Chesnel C; Turmel N; Sheikh Ismael S; Le Breton F; Amarenco G; Hentzen C
    Neurourol Urodyn; 2020 Apr; 39(4):1129-1136. PubMed ID: 32163639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between urinary bladder control and gait in women.
    Booth J; Paul L; Rafferty D; Macinnes C
    Neurourol Urodyn; 2013 Jan; 32(1):43-7. PubMed ID: 22693146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overground Robotic Program Preserves Gait in Individuals With Multiple Sclerosis and Moderate to Severe Impairments: A Randomized Controlled Trial.
    Berriozabalgoitia R; Bidaurrazaga-Letona I; Otxoa E; Urquiza M; Irazusta J; Rodriguez-Larrad A
    Arch Phys Med Rehabil; 2021 May; 102(5):932-939. PubMed ID: 33316225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to be Ready to Void: A new tool to assess the time needed to perform micturition for patients with multiple sclerosis.
    Hentzen C; Villaumé A; Turmel N; Miget G; Le Breton F; Chesnel C; Amarenco G
    Ann Phys Rehabil Med; 2020 Mar; 63(2):99-105. PubMed ID: 32014556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
    Denommé LT; Mandalfino P; Cinelli ME
    Exp Brain Res; 2014 Jun; 232(6):1811-22. PubMed ID: 24562410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.
    Dalgas U; Langeskov-Christensen M; Skjerbæk A; Jensen E; Baert I; Romberg A; Santoyo Medina C; Gebara B; Maertens de Noordhout B; Knuts K; Béthoux F; Rasova K; Severijns D; Bibby BM; Kalron A; Norman B; Van Geel F; Wens I; Feys P
    J Neurol Sci; 2018 Apr; 387():179-186. PubMed ID: 29571860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait Variability, Not Walking Speed, Is Related to Cognition in Adolescents With Multiple Sclerosis.
    Kalron A; Achiron A; Menascu S
    J Child Neurol; 2019 Jan; 34(1):27-32. PubMed ID: 30354845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the dynamic gait index in people with multiple sclerosis.
    Forsberg A; Andreasson M; Nilsagård YE
    Phys Ther; 2013 Oct; 93(10):1369-76. PubMed ID: 23641026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information processing speed and disease severity predict real-world ambulation in persons with multiple sclerosis.
    VanNostrand M; Bae M; Ramsdell JC; Kasser SL
    Gait Posture; 2024 Jun; 111():99-104. PubMed ID: 38657478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-day variability on short and long walking tests in persons with multiple sclerosis.
    Feys P; Bibby B; Romberg A; Santoyo C; Gebara B; de Noordhout BM; Knuts K; Bethoux F; Skjerbæk A; Jensen E; Baert I; Vaney C; de Groot V; Dalgas U
    J Neurol Sci; 2014 Mar; 338(1-2):183-7. PubMed ID: 24439144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a strong desire to void on gait for incontinent and continent older community-dwelling women at risk of falls.
    Paquin MH; Duclos C; Lapierre N; Dubreucq L; Morin M; Meunier J; Rousseau J; Dumoulin C
    Neurourol Urodyn; 2020 Feb; 39(2):642-649. PubMed ID: 31765490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
    Zörner B; Filli L; Reuter K; Kapitza S; Lörincz L; Sutter T; Weller D; Farkas M; Easthope CS; Czaplinski A; Weller M; Linnebank M
    Mult Scler; 2016 Oct; 22(11):1463-1475. PubMed ID: 26762672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
    Dray E; Cameron AP; Clemens JQ; Qin Y; Covalschi D; Stoffel J
    J Urol; 2018 Oct; 200(4):868-874. PubMed ID: 29702098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the strong desire to void a source of diverted attention in healthy adult volunteers?
    Gibson W; Morrison R; Wagg A; Hunter KF
    Neurourol Urodyn; 2020 Jan; 39(1):324-330. PubMed ID: 31782977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
    Di Filippo M; Proietti S; Gaetani L; Gubbiotti M; Di Gregorio M; Eusebi P; Calabresi P; Sarchielli P; Giannantoni A
    Eur J Neurol; 2014 Apr; 21(4):648-53. PubMed ID: 24471827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.